Company Number: 14719514

Analysis Date: 2025-07-29 20:09 UTC

Financial Health Assessment Report
Company: FLEX-GO ENERGY LIMITED | Financial Year End: 31 March 2024

---

1. Financial Health Score: B-

Explanation:
The company shows a very strong equity base with substantial shareholders’ funds (£99,999,399), indicating a well-capitalized position. However, its operational activity and cash flow remain minimal, as reflected by the low current assets (£49,999) and current liabilities (£50,600) almost balancing out. The net current assets figure appears disproportionately large (£99,999,399), which is likely due to accounting presentation of unpaid called-up share capital rather than liquid assets. This high capital injection supports solvency but the lack of trading history or operating revenues limits full financial health confidence at this stage.

---

2. Key Vital Signs: Critical Metrics and Interpretation

Metric	Value (£)	Interpretation
Called-up Share Capital	100,000,000	Extremely high capital injection; strong equity backing.
Cash at Bank	49,999	Limited cash reserves; potential liquidity constraint for operations.
Current Liabilities	50,600	Short-term obligations almost equal cash; tight working capital.
Net Current Assets	99,999,399	Inflated by unpaid share capital; not indicative of operational liquidity.
Net Assets (Equity)	99,999,399	Reflects strong shareholder funding; company is solvent.
Profit and Loss Account	-601	Minor accumulated loss; no significant trading profits yet.
Employees	0	No staff employed; company is in early stage or pre-trading.
Going Concern	Positive	Directors confirm adequate resources for foreseeable future.

---

3. Diagnosis: Underlying Business Health Insights

• Capital Structure ("Healthy Heartbeat"): The company’s core strength lies in its substantial equity capital, acting like a strong heart pumping financial lifeblood through the business. This large capital base means it can withstand initial trading losses or cash flow fluctuations without immediate distress.

• Liquidity Status ("Pulse Check"): The cash balance is limited (£49,999) and current liabilities are roughly equal, indicating a fragile liquidity state if the company were actively trading. The absence of net current assets from an operational perspective suggests that day-to-day cash flow management needs close attention once trading starts.

• Operational Activity ("Lack of Vital Signs"): No employees and negligible operational revenue or profit indicate the company is in the start-up phase or in preparation for trading. This is common for newly incorporated firms but represents a symptom of immature business activity.

• Accounting Presentation ("Symptom of Accounting Anomaly"): The unusually large net current assets figure is essentially an artifact of accounting for unpaid called-up share capital. This inflates balance sheet strength superficially but doesn't reflect liquid resources.

• Governance and Control ("Steady Nervous System"): The company is controlled by a single individual (Mr Hui Zhang), who holds all shares and voting rights, providing clear leadership but also concentration risk.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

1. Increase Operational Liquidity: Secure additional working capital or cash reserves, either through shareholder loans or operational cash flow, to ensure the company can meet short-term liabilities comfortably once trading begins.

2. Develop Revenue Streams: Focus on initiating commercial activity promptly to generate revenue and move from a pre-trading "clinical trial" phase to a healthy operating model with positive cash flow.

3. Implement Financial Controls: Establish robust cash flow management and budgeting processes to monitor liquidity closely and avoid "symptoms of distress" such as late payments or creditor pressure.

4. Transparency in Reporting: Consider clarifying the accounting presentation of called-up capital and operational assets/liabilities to provide stakeholders with clearer insight into financial health.

5. Risk Diversification: Evaluate governance structure to mitigate risks from concentration of control and plan for potential succession or additional directors for broader oversight.

---